Alternatives to OmnibusX

Delve into a vast collection of meticulously curated single-cell transcriptome datasets, as well as your own, using dynamic visualizations and analytical tools. This software is versatile, accommodating multimodal omics, CITE-seq, TCR-seq, and spatial transcriptomics. Engage with the most extensive single-cell expression database globally, where you can access and extract insights from a repository featuring millions of fully annotated cells complete with cell type labels and experimental metadata. Beyond merely serving as a conduit to published research, BioTuring Browser functions as a comprehensive end-to-end solution tailored for your specific single-cell data needs. Easily import your fastq files, count matrices, or Seurat and Scanpy objects to uncover the biological narratives contained within. With an intuitive interface, you can access an extensive array of visualizations and analyses, transforming the process of extracting insights from any curated or personal single-cell dataset into a seamless experience. Additionally, the platform allows for the importation of single-cell CRISPR screening or Perturb-seq data, enabling users to query guide RNA sequences with ease. This functionality not only enhances research capabilities but also facilitates the discovery of novel biological insights.

Nygen serves as a cloud-driven platform for the analysis and discovery of single-cell RNA sequencing (scRNA-seq) and multi-omics data, allowing researchers to seamlessly upload, explore, visualize, analyze, and interpret intricate cellular datasets through an easy-to-use, no-code interface that promotes drag-and-drop workflows and sophisticated scientific analysis without the need for programming knowledge. This platform merges Nygen Analytics for swift and reproducible exploration of scRNA-seq data with collaborative dashboards that produce publication-ready outputs, integrates Nygen Database for easy access to curated single-cell datasets to enhance research and comparative studies, and includes Nygen Insights, an AI-enhanced feature that offers precise cell annotations, thorough disease impact assessments, and customized biological insights. Furthermore, it accommodates a variety of data formats, integrates public datasets, fosters secure cloud collaboration, and offers functionalities such as literature-linked evidence and analyses focused on biomarkers, ultimately empowering researchers to derive meaningful conclusions from their data. By streamlining complex analytical processes, Nygen significantly enhances the efficiency of scientific research and discovery.

The QIAGEN CLC Geneomics Workbench is a powerful tool that works for all workflows. It is easy to overcome data analysis challenges with cutting-edge technology, unique features and algorithms that are widely used by scientists in industry and academia. Bioinformatics software solutions that are user-friendly allow for comprehensive analysis and interpretation of your NGS data. This includes de novo assembly and transcriptome assembly, resequencing analysis, WES and targeted panel support, variant calling, variant calling, RNA–seq, ChIP–seq and DNA methylation analysis (bisulfite sequence analysis). You can analyze your RNA-seq (miRNA, smallRNA) and smallRNA (lncRNA), data using easy-to-use transcriptomics workflows that allow for differential expression analysis at both gene and transcript levels. QIAGEN CLC Genomics Workbench was designed to support a wide variety of NGS bioinformatics programs.

Geneious Prime enhances access to bioinformatics by converting raw datasets into intuitive visual representations that facilitate sequence analysis in a user-friendly manner. It offers straightforward sequence assembly along with the convenient editing of contigs. Users benefit from automatic gene prediction, motif identification, translation, and variant calling through its annotation features. It also allows for the genotyping of microsatellite traces using automated ladder fitting and peak calling, producing comprehensive tables of alleles. The platform showcases beautifully designed visualizations of annotated genomes and assemblies, presented in a customizable sequence view that enhances user experience. Furthermore, it supports powerful analyses of SNP variants, simplifies RNA-Seq expression evaluations, and assists in amplicon metagenomics. Users can also design and test PCR and sequencing primers while developing their own searchable primer database. Additionally, Geneious Biologics provides a versatile, scalable, and secure solution to optimize workflows for antibody analysis, enabling the creation of high-quality libraries and the selection of the most suitable therapeutic candidates. This integration of tools fosters greater efficiency and innovation in biological research.

Cufflinks is a software tool that compiles transcripts, estimates their levels of abundance, and evaluates differential expression and regulation in RNA-Seq datasets. By accepting aligned RNA-Seq reads, it organizes these alignments into a streamlined representation of transcripts. The software then assesses the relative abundances of these transcripts based on the number of supporting reads, while also factoring in potential biases from library preparation methods. Initially created through a collaboration with the Laboratory for Mathematical and Computational Biology, Cufflinks aims to simplify the installation process by offering several binary packages that alleviate the often cumbersome task of building the software from source, which necessitates the installation of various libraries. This toolset encompasses multiple utilities tailored for analyzing RNA-Seq experiments, with some functionalities available independently and others designed to fit into a more comprehensive workflow. Overall, Cufflinks serves as a vital resource for researchers in the field of genomics, enhancing their ability to interpret RNA-Seq data effectively.

Correlation Engine serves as an engaging omics knowledgebase designed to situate private omics data within a rich biological framework alongside meticulously curated public datasets. Recognized as one of the most extensive biological databases globally, it offers life science researchers unparalleled access to an immense collection of high-quality whole-genome analyses, complemented by powerful scientific tools. This knowledgebase fosters groundbreaking discoveries by enabling the exploration of billions of data points sourced from standardized whole genome study analyses. It features an array of applications tailored for discerning biological context, a continuously expanding library of curated datasets, and versatility across various species and multi-omic datasets. Users can navigate through an intuitive graphical user interface that facilitates guided workflows, one-click applications, and application programming interfaces (APIs). By streamlining the transition from omic data to actionable insights, researchers can tap into over 25,000 multi-omics studies derived from more than 250,000 unique signatures that have undergone reanalysis, thereby enhancing their research capabilities even further.

Created within the Data Sciences Platform at the Broad Institute, this comprehensive toolkit provides an extensive array of features primarily aimed at variant discovery and genotyping. With its robust processing engine and high-performance computing capabilities, it is equipped to manage projects of any magnitude. The GATK has established itself as the industry benchmark for detecting SNPs and indels in both germline DNA and RNA sequencing data. Its functionalities are now broadening to encompass somatic short variant detection as well as addressing copy number variations (CNV) and structural variations (SV). Besides the core variant callers, the GATK incorporates numerous utilities for executing associated tasks, including the processing and quality assurance of high-throughput sequencing data, and it comes bundled with the well-known Picard toolkit. Originally designed for exome and whole genome data generated via Illumina sequencing technology, these tools are versatile enough to be modified for use with various other technologies and study designs. As research evolves, the adaptability of the GATK ensures it remains relevant in diverse genomic investigations.

Claude for Life Sciences is an AI-driven research platform created by Anthropic, specifically designed to enhance workflows in the life sciences sector, including areas like drug discovery, experimental design, and regulatory documentation. This innovative solution merges Claude’s advanced language model capabilities with essential research environments and data sources, establishing connections with platforms such as laboratory information systems, genomic analysis tools, and biomedical databases. This integration allows scientists to progress effortlessly from formulating hypotheses to interpreting data and producing publication-ready documents. Moreover, the system features specialized “skills” and connectors tailored for life sciences applications; for instance, it includes a skill for quality control in single-cell RNA sequencing and integrates with spatial biology toolchains, facilitating meaningful interactions with analytical workflows instead of merely handling raw prompts. By incorporating itself into existing processes, the platform demonstrates performance that surpasses human baseline standards in protocol comprehension tasks and accommodates natural-language inquiries, significantly improving overall research efficiency. This advancement not only streamlines complex scientific tasks but also empowers researchers to focus on innovation and discovery.

Choose two tailored cell groups by utilizing metadata to uncover their most significantly differentially expressed genes. Utilize the extensive collection of millions of cells from the integrated CZ CELLxGENE corpus for in-depth analysis. Conduct interactive examinations of datasets to investigate how gene expression patterns are influenced by spatial, environmental, and genetic variables through an intuitive no-code user interface. Gain insights into existing datasets or leverage them as a foundation to discover new cell subtypes and states. Census offers the capability to access any customized segment of standardized cell data available within CZ CELLxGENE, with opportunities for exploration in both R and Python. Delve into an interactive encyclopedia containing over 700 cell types that includes comprehensive definitions, marker genes, lineage information, and associated datasets all in one location. Additionally, you can browse and obtain hundreds of standardized data collections along with more than 1,000 datasets that detail the functionality of both healthy mouse and human tissues, enriching your research and understanding of cellular biology. This resource provides a valuable tool for researchers aiming to enhance their exploration of cellular dynamics and gene expression.

Transform your single-cell RNA sequencing data into actionable insights using Cellenics software, which is hosted by Biomage as a community instance of this open-source analytics tool developed at Harvard Medical School. This platform empowers biologists to delve into single-cell datasets without the need for coding, while facilitating collaboration between scientists and bioinformaticians. Within just a few hours, it can convert count matrices into publication-ready figures, integrating effortlessly into your existing workflow. Cellenics is designed to be fast, interactive, and user-friendly, as well as being cloud-based, secure, and scalable to meet various research needs. The community instance provided by Biomage is available at no cost for academic researchers working with smaller to medium-sized datasets, accommodating up to 500,000 cells. Currently, over 3000 academic researchers engaged in studies related to cancer, cardiovascular health, and developmental biology are utilizing this powerful tool. This collaborative environment not only enhances research capabilities but also accelerates the discovery process in various scientific fields.

Evo 2 represents a cutting-edge genomic foundation model that excels in making predictions and designing tasks related to DNA, RNA, and proteins. It employs an advanced deep learning architecture that allows for the modeling of biological sequences with single-nucleotide accuracy, achieving impressive scaling of both compute and memory resources as the context length increases. With a robust training of 40 billion parameters and a context length of 1 megabase, Evo 2 has analyzed over 9 trillion nucleotides sourced from a variety of eukaryotic and prokaryotic genomes. This extensive dataset facilitates Evo 2's ability to conduct zero-shot function predictions across various biological types, including DNA, RNA, and proteins, while also being capable of generating innovative sequences that maintain a plausible genomic structure. The model's versatility has been showcased through its effectiveness in designing operational CRISPR systems and in the identification of mutations that could lead to diseases in human genes. Furthermore, Evo 2 is available to the public on Arc's GitHub repository, and it is also incorporated into the NVIDIA BioNeMo framework, enhancing its accessibility for researchers and developers alike. Its integration into existing platforms signifies a major step forward for genomic modeling and analysis.

Loupe Browser stands out as a robust visualization tool, offering the user-friendly capabilities essential for delving into and interpreting 10x Genomics Chromium and Visium datasets. Additionally, the LoupeR package facilitates the transformation of Seurat objects into files compatible with Loupe Browser. The interactive features of the Loupe Browser interface are exemplified through its use of a lung squamous cell carcinoma dataset. Central to the user experience is the view panel, where individual points, each representing cell barcodes, are displayed across multiple projections. Each point typically corresponds to a single cell’s barcode, enabling focused analysis. The t-SNE plot generated by the cell ranger pipeline serves as the default projection, while alternative visualization options are also accessible. Users can effortlessly reposition the plot by dragging the mouse over the cells and can zoom in or out using the mouse wheel or trackpad. Moreover, as the mouse hovers over the plot, cluster labels become visible, which proves particularly beneficial when working with datasets that contain numerous precomputed clusters. This capability enhances the analytical experience, making it easier to identify and interpret complex data patterns.

OmicsBox, a leading bioinformatics tool, offers end-toend data analysis for genomes, transcriptomes and metagenomes. It also provides genetic variation studies. The application, which is used by leading private and public research institutes worldwide, allows researchers to process large and complicated data sets and streamline their analytical process. It is designed to be efficient, user-friendly and equipped with powerful tools to extract biological insight from omics data. The software is divided into modules, each of which has a set of tools and features designed to perform specific types of analyses, such as de novo genome assemblies, genetic variations analysis, differential expression analyses, taxonomic classifications, and taxonomic classes of microbiome, including the interpretation of results and rich visualizations. The functional analysis module uses the popular Blast2GO annotating methodology, making OmicsBox a great tool for non-model organisms research.

Partek bioinformatics software offers robust statistical and visualization capabilities through a user-friendly interface that caters to researchers of varying expertise. This innovation allows users to navigate genomic data with unprecedented speed and ease, truly embodying our motto, "We turn data into discovery®." With pre-installed workflows and pipelines in a simple point-and-click format, even complex NGS and array analyses become accessible to all scientists. Our combination of custom and public statistical algorithms works seamlessly to transform NGS data into valuable biological insights. Engaging visual tools like genome browsers, Venn diagrams, and heat maps illuminate the intricacies of next-generation sequencing and array data with vibrant clarity. Additionally, our team of Ph.D. scientists is always available to provide support for NGS analyses whenever queries arise. Tailored to meet the demanding computational requirements of next-generation sequencing, the software also offers flexible options for installation and user management, ensuring a comprehensive solution for research needs. As a result, users can focus more on their research and less on technical challenges.

Pluto was founded in 2021 by the Wyss Institute of Harvard University. It has been a trusted partner for many life sciences organizations across the country, from biotech start-ups and public biopharma companies. Our cloud-based platform allows scientists to manage all their data, run bioinformatics analysis, and create interactive visualizations that are published-quality. The platform is being used for a variety of biological applications. These include preclinical and translational science research, cell and gene therapies and drug discovery and development.

Combinatorial barcoding technology revolutionizes the outdated limitations of traditional single-cell methodologies. By eliminating the need for specialized instruments, it empowers researchers to make groundbreaking discoveries with ease. This innovation allows for the profiling of anywhere from 1,000 to 1 million cells or nuclei in a single experiment, driving forward unparalleled advancements in science. Evercode combinatorial barcoding technology significantly outperforms droplet-based methods, enabling researchers to increase the scale of their experiments without the constraints of previous technologies. Enjoy enhanced data quality while avoiding the complexities and requirements of outdated hardware. Conduct single-cell experiments using only a pipette and standard laboratory tools, simplifying the process and making it more accessible. The split-pool combinatorial barcoding technique facilitates scalable single-cell analysis without relying on any specialized instruments, making it easier than ever to achieve scalable sequencing. Each kit includes a comprehensive set of reagents and user-friendly analysis software, streamlining the entire workflow from start to finish for optimal efficiency. This technology not only enhances research capabilities but also fosters a new era of accessibility in scientific exploration.

Profluent's innovative platform transforms the field of protein design by seamlessly combining cutting-edge AI technology with its own experimental capabilities, allowing for the development of proteins that are either inspired by nature or entirely newly conceived. This comprehensive methodology provides precise, flexible, and scalable solutions to intricate biological problems, resulting in advancements that push the boundaries of protein functionality. Profluent's foundational models extend protein design beyond the constraints of traditional random approaches, enabling the simultaneous optimization of various characteristics, enhancing sequence diversity, and unlocking new functionalities. By venturing into unexplored protein territories, Profluent presents distinctive opportunities that surpass the limitations of natural or patented proteins, streamlining the process for partners to achieve commercial viability in a more cost-effective and accessible manner. Underpinning Profluent's capabilities is a strong dedication to scientific excellence, utilizing a wide range of datasets and advanced AI techniques to address complex challenges effectively. As a result, Profluent not only advances protein engineering but also sets a new standard in the industry, fostering innovative collaborations and breakthroughs.

Evo Designer is a cutting-edge tool created by the Arc Institute, harnessing the power of the Evo 2 genomic foundation model to aid in the generation and analysis of DNA sequences. Users can enter nucleotide sequences or select specific organisms, prompting the model to produce relevant DNA sequences tailored to their needs. This platform also offers detailed annotations of coding regions and provides 3D protein visualizations for prokaryotic sequences through ESMFold, enhancing the understanding of protein structures. In addition to these features, Evo Designer evaluates sequences by calculating their perplexity and per-nucleotide entropy, which helps researchers gauge the complexity and variability of the sequences they are working with. The Evo 2 model at the core of this tool has been trained on an impressive dataset of over 9 trillion nucleotides sourced from a wide variety of prokaryotic and eukaryotic genomes. Utilizing a sophisticated deep learning architecture, it models biological sequences with single-nucleotide precision and boasts a context window that can extend up to 1 million tokens, thereby ensuring high accuracy in sequence representation and analysis. This combination of features makes Evo Designer an invaluable resource for genetic research and exploration.

Manage, store, and collaborate on multi-omic datasets effectively. The Illumina Connected Analytics platform serves as a secure environment for genomic data, facilitating the operationalization of informatics and the extraction of scientific insights. Users can effortlessly import, construct, and modify workflows utilizing tools such as CWL and Nextflow. The platform also incorporates DRAGEN bioinformatics pipelines for enhanced data processing. Securely organize your data within a protected workspace, enabling global sharing that adheres to compliance standards. Retain your data within your own cloud infrastructure while leveraging our robust platform. Utilize a versatile analysis environment, featuring JupyterLab Notebooks, to visualize and interpret your data. Aggregate, query, and analyze both sample and population data through a scalable data warehouse, which can adapt to your growing needs. Enhance your analysis operations by constructing, validating, automating, and deploying informatics pipelines with ease. This efficiency can significantly decrease the time needed for genomic data analysis, which is vital when rapid results are essential. Furthermore, the platform supports comprehensive profiling to uncover novel drug targets and identify biomarkers for drug response. Lastly, seamlessly integrate data from Illumina sequencing systems for a streamlined workflow experience.

BigOmics Analytics is an innovative startup focused on biodata analytics, creating platforms that empower biologists to effectively visualize and interpret their omics data. Our primary offering, Omics Playground, is a highly intuitive bioinformatics tool tailored for RNA-seq and proteomics, enabling users to store their experimental data and visualize it interactively. With more than 18 interactive analysis modules and over 150 dynamic plots, the platform supports co-analysis with a vast array of more than 6,000 public datasets, in addition to providing access to more than 50,000 public gene sets and pathways. Furthermore, it seamlessly incorporates drug connectivity and drug sensitivity databases, featuring an extensive collection of over 30,000 drug expression profiles. BigOmics Analytics is designed to promote collaboration between biologists and bioinformaticians, allowing users to uncover insights while minimizing the time spent on data analysis, all without the need for any programming knowledge. The platform's commitment to producing reliable and reproducible results is achieved through the implementation of state-of-the-art methodologies. Ultimately, BigOmics Analytics is revolutionizing the way biological data is analyzed and understood.

g.nome is a cloud-native platform designed to offer efficient, scalable, and interoperable workflows tailored for next-generation sequencing analysis. It features a low-code/no-code approach to building pipelines, allowing users to access a curated library of pre-built workflows and toolkits. This empowers researchers to easily import their custom code, manage large datasets with confidence, and enhance collaboration among team members, regardless of their location. By utilizing g.nome, researchers can eliminate longstanding obstacles related to workflow languages, visibility of process flows, and quality assurance. Consequently, they can concentrate entirely on their scientific endeavors, as g.nome transforms the complexities of genomic workflows into streamlined, efficient processes. This innovative platform not only simplifies research but also fosters an environment where scientific inquiry can thrive unhindered.

The immune system is essential for our biological processes, acting as a shield against illnesses and maintaining internal balance by fending off external threats like pathogens. Each individual's immune composition is unique and continually adapts over time, and by thoroughly mapping and examining this intricate system, we can gain valuable insights that propel research forward and lead to improved treatments for everyone. Unfortunately, the analysis of single-cell data has historically not kept pace with the advancements in technology that produce this data. Traditional manual workflows, which are constrained by their resolution and speed, limit the amount of cellular information that can be accessed. As medicine increasingly moves towards precision treatments, many cutting-edge therapies are being developed using the patient's own immune cells. Our AI-enhanced computational analysis tools are designed to reveal critical insights that facilitate the discovery and progression of innovative therapies, ultimately benefiting patient care. This ongoing evolution in our understanding of the immune system and its complexities is vital for shaping future medical breakthroughs.

Cease the struggle with cloud infrastructure and unreliable informatics tools; begin uncovering biological insights immediately. The scientific exploration process is hindered by the disjointed nature of tools utilized by biology and bioinformatics teams. To address this issue, we developed a unified bioinformatics platform that bridges the gap between wet lab and dry lab operations in the cloud, enabling teams to expedite their research and development efforts. You can easily import raw data from your cloud, your service provider, or your team's instruments with minimal hassle. Create and implement tailored bioinformatics workflows in various programming languages without the frustration of complex infrastructure management. Effortlessly execute any workflow while maintaining a comprehensive log of every analysis performed. Our platform features ready-to-use interactive visualizations for NGS data that allow you to create point-and-click plots with ease. Additionally, Latch seamlessly integrates with your organization’s AWS S3, granting access to hundreds of terabytes of data within a user-friendly organic filesystem. You can define bioinformatics workflows and dynamically generate no-code interfaces using Python, with adjustable compute and storage options to suit your needs. This innovative approach not only streamlines the research process but also fosters collaboration among teams, ultimately leading to more impactful scientific discoveries.

VarSeq is a user-friendly and efficient software designed for conducting variant analysis on gene panels, exomes, and complete genomes. This comprehensive software solution simplifies tertiary analysis, allowing users to effortlessly automate their workflows and examine variants across various genomic contexts. With VarSeq, the complexities of genomic data become more manageable, enabling researchers to easily navigate and interpret results. The software features a robust filtering and annotation system that helps users efficiently process extensive variant datasets. By employing a sequence of filters, you can swiftly refine your variant list to highlight those of greatest relevance. Once you establish effective parameters for your analysis, VarSeq allows you to save your filter configurations, facilitating the application of the same analytical approach to different datasets. This automated workflow can be consistently utilized across multiple sample batches, making VarSeq particularly suitable for high-throughput settings. Additionally, real-time filtering capabilities empower users to rapidly prototype and adjust analysis workflows according to their specific needs, enhancing the overall research experience. As a result, VarSeq significantly streamlines the variant analysis process for genetic studies.

Amazon Bio Discovery is an innovative application leveraging AI to enhance the efficiency of early-stage drug discovery by fusing computational biology models with practical laboratory testing in a cohesive "lab-in-the-loop" approach. This tool empowers researchers by granting them immediate access to an extensive library of biological foundation models developed from vast biological datasets, facilitating the rapid generation and assessment of potential drug candidates, including antibodies, with improved accuracy and speed. Additionally, the platform features an integrated AI agent that allows users to engage in natural language conversations to choose suitable models, set up experiments, and fine-tune inputs, eliminating the need for advanced programming skills or complex infrastructure. Researchers can also create multi-step workflows that integrate various models, evaluate their efficacy, and share workflows among teams, thereby fostering better collaboration between computational biologists and laboratory scientists. Ultimately, this powerful tool aims to streamline the drug discovery process and enhance scientific innovation in the field.

SciSpace BioMed serves as an innovative AI-powered "co-scientist" tailored for the field of biomedical research, integrating an extensive literature repository with over 150 bio-tools and more than 100 academic databases and software applications to enhance intricate research processes, which encompass areas such as genomics, single-cell analysis, drug discovery, and clinical genomics. This platform empowers researchers to pose questions in natural language, manage datasets, analyze variants or multi-omics results, plan experimental workflows, reason about clinical biology and diseases, and produce publication-ready materials, including figures, tables, and presentations, all while ensuring transparency and proper citations. Furthermore, users have the capability to engage with scientific articles through a “chat with PDF” feature that allows them to highlight and seek clarification on challenging text, mathematical content, or tables, making it an excellent tool for grasping complex methods or concepts. For the purposes of literature review or preliminary research, its AI-enhanced semantic search can sift through millions of academic papers, providing citation-supported summaries that facilitate deeper understanding and exploration of the relevant literature. This functionality significantly accelerates the research process, allowing scientists to focus more on their discoveries rather than administrative tasks.

Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.

Efficiently address tissue heterogeneity and the intricacies of microenvironments using the GeoMx Digital Spatial Profiler (DSP), which stands out as the most versatile and powerful spatial multi-omic platform for examining both FFPE and fresh frozen tissue sections. Unique among spatial biology platforms, GeoMx allows for non-destructive profiling of RNA and protein expression across various tissue compartments and cell populations, supported by an automated and scalable workflow that seamlessly integrates with conventional histology staining. You can spatially profile the entire transcriptome along with over 570 protein targets, either separately or concurrently, utilizing sample inputs such as whole tissue sections, tissue microarrays (TMAs), or organoids. By choosing GeoMx DSP, you position yourself at the forefront of spatial biology for effective biomarker discovery and hypothesis validation. With the ability to determine the relevant boundaries, you can rely on biology-driven profiling that enables you to focus on the tissue microenvironments and cell types that hold the most significance for your research. This innovative approach ensures that your analyses are both comprehensive and tailored to the specific biological contexts of interest.

Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.

The Bioconductor initiative is dedicated to creating and distributing open-source software for the accurate and reproducible analysis of biological data. We promote a welcoming and cooperative environment for developers and data scientists alike. Our resources are designed to unlock the full potential of Bioconductor. From foundational tools to sophisticated functionalities, our extensive tutorials, guides, and documentation cater to all user needs. Utilizing the R programming language, Bioconductor embraces both open-source principles and collaborative development. It features biannual releases and boasts a vibrant user community. Additionally, Bioconductor offers Docker images for each release and facilitates its integration within AnVIL. Established in 2001, Bioconductor has become a prominent open-source project within the realms of bioinformatics and biomedical research. It encompasses over 2,000 R packages contributed by upwards of 1,000 developers and experiences more than 40 million annual downloads. Furthermore, Bioconductor has been referenced in over 60,000 scientific publications, underscoring its significant impact on the research community. The ongoing growth and evolution of Bioconductor continue to support advancements in biological data analysis.

Genedata Biologics® enhances the development of biotherapeutics, including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs, providing a comprehensive solution for the industry. Recognized as the leading platform in the field, it seamlessly unifies all discovery workflows, allowing researchers to prioritize genuine innovation. By utilizing a pioneering platform that was purposefully created to digitalize the biotherapeutic discovery process, research can be accelerated significantly. The platform simplifies intricate R&D tasks by facilitating the design, tracking, testing, and evaluation of novel biotherapeutic drugs. It is compatible with various formats, such as antibodies, bi- or multi-specifics, ADCs, innovative scaffolds, and therapeutic proteins, as well as engineered therapeutic cell lines like TCRs and CAR-T cells. Functioning as a comprehensive end-to-end data backbone, Genedata Biologics connects all R&D processes, including library design, immunization, selection and panning, molecular biology, screening, protein engineering, expression, purification, and protein analytics, ultimately leading to thorough assessments of candidate developability and manufacturability. This holistic integration ensures that researchers can make informed decisions and push the boundaries of biotherapeutic innovation effectively.

Discover the ideal approach to managing biologics within the industry through a state-of-the-art, cloud-based software that fulfills all your requirements. Organizations often struggle with outdated Blood Establishment Computer Software (BECS) because they must adapt their workflows to align with the limitations of the software. The optimal solution for your organization is one that aligns with your specific needs rather than forcing you to conform to its framework, enabling you to enhance your efficiency in serving your community. With over four decades of expertise in software development and the biological sector, ForLife is dedicated to advancing capabilities for the future. Our extensive background in innovation and customer support culminates in the ultimate biologics software solution you’ll ever require, whether you represent a community blood center in need of blood bank management or a cell therapy laboratory seeking improved oversight. Embrace a system that not only meets your current needs but also adapts as your organization evolves and grows.

SeqOne is an advanced genomic analysis platform powered by artificial intelligence, aimed at enabling molecular laboratories, clinical teams, biologists, and geneticists to convert intricate next-generation sequencing data into quick, accurate, and actionable clinical insights that aid in personalized medicine diagnostics. By streamlining the entire genomic workflow—from handling raw sequencing data to variant interpretation and reporting—this platform automates routine tasks, integrates smoothly with laboratory systems, and employs sophisticated AI models like DiagAI to assess and prioritize disease-related variants, thereby minimizing manual labor and shortening turnaround times. SeqOne is versatile, catering to both germline and somatic analyses across various fields such as oncology, rare inherited diseases, and infectious disease detection, while it combines high-quality annotation databases and standardized interpretation protocols to ensure clinical-grade precision. Furthermore, it features an intuitive user interface that can scale securely through the cloud, making it accessible and efficient for diverse clinical environments. Ultimately, SeqOne represents a significant advancement in genomic analysis technology, fostering enhanced diagnostic capabilities in the realm of personalized medicine.

IPA can also help analyze small-scale experiments that produce gene and chemical lists. IPA allows for targeted searches on genes, chemicals, and drugs. It also allows the creation of interactive models of experimental system. Data analysis and search capabilities allow for the understanding of the significance of data, targets, or candidate biomarkers within larger biological or chemical systems. The Ingenuity Knowledge Base contains highly structured, detail-rich chemical and biological findings that backs the software. Learn more about QIAGEN Ingenuity Pathway Analysis. Comparison Analysis determines which pathways, upstream regulators and diseases are most important. It can also be used to identify biological functions across time, doses, and other conditions.

BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.

Seqera is an innovative bioinformatics platform crafted by the team behind Nextflow, aimed at optimizing and improving the oversight of scientific data analysis workflows. It provides a robust array of tools, such as the Seqera Platform for managing scalable data pipelines, Seqera Pipelines that grant access to a handpicked selection of open-source workflows, Seqera Containers to facilitate container management, and Seqera Studios that create interactive environments for data analysis. The platform is designed to integrate smoothly with a variety of cloud and on-premises systems, promoting reproducibility and compliance within scientific research. Users can incorporate Seqera into their existing infrastructures, including major cloud services like AWS, GCP, and Azure, all without the need for mandatory migrations. This flexibility allows for total control over data residency while enabling global scalability, ensuring that security and performance are never compromised. Furthermore, Seqera empowers researchers to enhance their analytical capabilities while maintaining a seamless operational flow within their established systems.

Modul-Bio offers tailored biobanking solutions aimed at assisting laboratories and research institutions in the management, tracking, and sharing of biological samples throughout their entire lifecycle. The company's flagship offering, MBioLIMS BioBanking, is a bespoke Laboratory Information Management System specifically crafted for biobanks, Biological Resource Centres, and cohort initiatives, enhancing the management of biological sample collections and their related data. This platform facilitates comprehensive traceability from the initial collection and receipt of samples, through to aliquoting, analysis, storage, and distribution, accommodating both single-site and multi-site collaborative efforts. To further enhance its core platform, Modul-Bio includes MBioLABEL, which offers cryogenic labels, barcode printers, and readers that enable long-term physical tracking of samples, even at extremely low temperatures. Additionally, the eMBioBANK provides a secure, web-based portal that enables organizations to publish and share their catalogs of biological samples, thus fostering collaboration and accessibility in research. By integrating these innovative tools, Modul-Bio ensures that researchers have the resources they need for effective sample management and collaboration.

CryoTrackIMS is a comprehensive software solution tailored for various fields, including molecular biology, cell banking, cellular biology, clinical samples, biorepositories, biobanking, biochemistry, immunology, and protein laboratories, as well as high-throughput screening, quality assurance, IVF labs, and core facilities. Users can effortlessly design any box, plate, or pie layout by choosing from rows and columns or opting for a pie configuration, allowing their custom box to be generated in mere seconds for data input. Efficient inventory management of precious biological samples and specimens is essential for both fundamental research and the biotech industry. Managing extensive collections of diverse samples such as DNA, RNA, plasmids, clones, proteins, peptides, probes, antibodies, enzymes, specimens, tissues, and cell lines can often become a challenging and overwhelming endeavor that results in significant financial costs alongside frustration and wasted time. CryoTrack provides an all-encompassing solution specifically designed for laboratories within universities, clinics, biotechnology firms, and pharmaceutical organizations. This advanced software not only simplifies sample tracking but also significantly enhances lab efficiency and productivity. By streamlining the organization of critical biological materials, CryoTrackIMS empowers researchers to focus more on their experiments and less on administrative burdens.

The innovative XetaBase platform streamlines tertiary analysis by aggregating, indexing, and enriching secondary genomic data, which facilitates ongoing re-evaluation to reveal valuable insights for research and clinical applications. By enhancing data management practices, XetaBase allows for the economical utilization of genomic information both in laboratories and clinical settings. The platform is designed to handle expansive genomic datasets, where increased volume and complexity lead to improved insights and outcomes. Built on the open-source OpenCB software framework, XetaBase is a genomic-native technology that addresses the demands for scalability, speed, and innovative re-interpretation in genomic medicine. Zetta Genomics provides an advanced genomic data management solution tailored for the era of precision medicine. This transformative platform eliminates outdated flat file methods, introducing actionable and relevant genomic data into both laboratory and clinical environments. Furthermore, XetaBase not only supports ongoing re-interpretation but also adapts effortlessly as databases expand to include more comprehensive genome sequences, ensuring that users stay at the forefront of genomic advancements.

The Illumina DRAGEN Secondary Analysis system offers precise, thorough, and highly efficient processing of next-generation sequencing data. Utilizing a graph reference genome alongside machine learning techniques, it achieves remarkable accuracy. The workflow is exceptionally streamlined, capable of completely analyzing a 34x whole human genome in approximately 30 minutes when using the DRAGEN server v4. Additionally, it enhances this workflow by compressing FASTQ file sizes by up to five times. This system is adept at analyzing a variety of NGS data types, including whole genomes, exomes, methylomes, and transcriptomes. It is designed to be compatible with the user's preferred platform and is scalable to meet varying requirements. DRAGEN analysis consistently ranks as a leader in accuracy for both germline and somatic variant detection, as evidenced by its performance in industry competitions conducted by precisionFDA. This advanced analysis solution empowers laboratories of all sizes and specialties to maximize the potential of their genomic datasets. Moreover, the implementation of highly adaptable field-programmable gate array (FPGA) technology allows DRAGEN to deliver hardware-accelerated genomic analysis algorithms, further enhancing its performance. Such advancements position DRAGEN as a vital tool in the ever-evolving field of genomics.

Edison Scientific is an innovative AI platform that streamlines and expedites scientific research, allowing users to transition from developing hypotheses to obtaining validated results all within one cohesive environment. This platform seamlessly integrates workflows for literature synthesis, data analysis, and molecular design, enabling research teams to conduct comprehensive scientific investigations at a significantly faster pace. Central to its functionality is Kosmos, an autonomous research system capable of executing hundreds of research tasks simultaneously, which converts multimodal datasets into detailed reports featuring validated findings and figures ready for publication. Kosmos adeptly synthesizes information from scientific literature, public databases, and proprietary datasets, while also identifying new therapeutic targets, revealing biological mechanisms, and facilitating the iterative design and refinement of molecular candidates. Proven effective in real-world research contexts, Kosmos has showcased the capability to deliver results that would typically take months of human labor in just one day, revolutionizing the efficiency of scientific research and development. This remarkable speed not only enhances productivity but also empowers researchers to focus on more complex challenges in their fields.

Geneyx Analysis offers an all-encompassing solution for managing next-generation sequencing (NGS) data, efficiently transforming FASTQ files into clinical reports tailored for both hospital and commercial laboratories. This cutting-edge platform incorporates machine learning and artificial intelligence capabilities to uncover new biomedical insights, enhancing diagnostic efficiency and reducing turnaround times. By delivering a fully transparent and user-friendly interface, Geneyx Analysis empowers clinicians and researchers with complete control over data interpretation and simplifies the challenges associated with managing in-house bioinformatics workflows. Users can customize protocols to suit various gene panels, exomes, and genomes, while our extensive annotation engine facilitates the analysis of all genetic variants, including structural and copy number variations, as well as regulatory elements. In combination, Geneyx Analysis streamlines the diagnostic journey from sequencer output to finalized report, while also serving as a valuable resource for the discovery of novel variants. This platform not only enhances clinical capabilities but also paves the way for groundbreaking research in genomics.

Eidogen-Sertanty's Target Informatics Platform (TIP) stands out as the pioneering structural informatics system and knowledgebase that empowers researchers to explore the druggable genome through a structural lens. By harnessing the burgeoning wealth of experimental protein structure data, TIP revolutionizes structure-based drug discovery, shifting it from a limited, low-throughput field to a dynamic and data-rich scientific discipline. It is specifically designed to connect the realms of bioinformatics and cheminformatics, providing drug discovery scientists with a repository of insights that are not only unique but also highly synergistic with the information available from traditional bio- and cheminformatics tools. The platform's innovative combination of structural data management with advanced target-to-lead calculation and analytical capabilities significantly enhances every phase of the drug discovery process. With TIP, researchers are better equipped to navigate the complexities of drug development and make informed decisions.

Orbit BioSequence from Questel is an advanced tool for intellectual property (IP) intelligence, tailored to assist researchers, patent experts, and biotech firms in the thorough analysis and management of biological sequence data within the IP realm. This software presents a sophisticated framework for scrutinizing, analyzing, and keeping track of nucleotide and protein sequences identified in patent documents, thereby providing users with unprecedented access to vital sequence information that is essential for fostering innovation and conducting competitive assessments. With Orbit BioSequence, users can execute highly precise similarity and identity searches throughout international patent databases, empowering organizations to pinpoint existing patents, mitigate infringement risks, and discover potential licensing or collaboration opportunities. Furthermore, the software employs state-of-the-art search algorithms alongside meticulously curated datasets, guaranteeing both accuracy and relevance in the results. The comprehensive nature of this tool positions it as an invaluable resource in the evolving landscape of biotechnology and intellectual property management.

Efficient data management and streamlined bioinformatics solutions are essential for laboratories that are either just beginning or rapidly expanding their next-generation sequencing (NGS) capabilities. As an integral part of the BaseSpace Suite, BaseSpace Sequence Hub serves as a seamless extension to your Illumina instruments. The encrypted data transmission from these instruments into BaseSpace Sequence Hub simplifies the management and analysis of your data through a selection of specialized analysis applications. Built on the robust Amazon Web Services (AWS), BaseSpace Sequence Hub prioritizes security, ensuring a safe environment for your data. It allows users to initiate sequencing runs and monitor the quality of instrument operations effectively. This system enhances productivity by converting sequencing data into a standardized format and facilitating direct cloud streaming. Additionally, it grants access to necessary computational resources without the need for significant investments in on-premises infrastructure. Ultimately, it boosts organizational efficiency by providing easy access to a wide array of genomic analysis applications, whether developed by you, Illumina, or third-party providers, thus fostering innovation and progress in genomic research.